Literature DB >> 15713709

Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls.

Madhusmita Misra1, Karen K Miller, Cecilia Almazan, Megan Worley, David B Herzog, Anne Klibanski.   

Abstract

We have previously demonstrated that girls with anorexia nervosa (AN) have higher levels of GH and cortisol and lower levels of estradiol than healthy adolescents. The effects of endocrine alterations on regional body composition in AN, however, have not been reported. We, therefore, enrolled 23 adolescent girls with AN and 20 healthy girls of comparable maturity in a study examining regional body composition. Levels of estradiol and IGF-I, as well as measures of GH and cortisol concentration (using cluster analysis of data obtained from frequent sampling q30' for 12 h overnight) were examined to determine hormonal determinants of regional body composition in adolescent girls with AN and controls. Girls with AN were followed for 1 yr and examined again at weight recovery (10% increase in body mass index) (n = 11). Percent trunk fat and trunk to extremity fat ratio (T/E fat) were significantly reduced in girls with AN compared with healthy adolescents (P = 0.001 and 0.01, respectively). Percent trunk lean mass and trunk to extremity lean mass ratio (T/E lean) were higher in AN than in controls (P = 0.01 and 0.009); percent extremity lean mass was lower in AN (P = 0.009). In healthy controls, total area under the curve (AUC) for GH correlated inversely with percent trunk fat and T/E fat (r = -0.66, P = 0.002 and r = -0.62, P = 0.003). Similar correlations were observed between other measures of GH concentration (mean and nadir) and percent trunk fat and T/E fat. No relationship was observed between GH concentration and regional lean mass or between cortisol concentration and regional body composition. In contrast, GH concentration did not predict regional body composition in adolescents with AN on regression analysis. However, nadir cortisol concentration correlated inversely with percent extremity lean mass (r = -0.49; P = 0.02) and positively with percent trunk lean mass and T/E lean (r = 0.48, P = 0.03; and r = 0.49, P = 0.02) in girls with AN. A similar trend was observed between other measures of cortisol concentration (mean cortisol and AUC) and percent trunk lean mass and T/E lean in AN. Trunk fat was lowest in girls with AN who had high GH but low cortisol levels (based on median values), whereas some preservation of trunk fat was observed in girls with low GH and high cortisol levels. Weight recovery occurred in seven of 11 girls with low GH and high cortisol values; however, only two of the nine girls with high GH and low cortisol recovered weight. High GH with lower cortisol levels may thus be a marker of greater severity of AN. Our results suggest that in healthy controls, GH concentration predicts regional body composition and favors a redistribution of body fat such that T/E fat ratio decreases. In AN, however, high levels of GH and cortisol have contrasting associations with fat mass. High cortisol levels in AN predict a redistribution of lean body mass such that extremity lean mass decreases. Further studies are necessary to better understand the implications of these data.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713709     DOI: 10.1210/jc.2004-2041

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

Review 1.  The endocrine manifestations of anorexia nervosa: mechanisms and management.

Authors:  Melanie Schorr; Karen K Miller
Journal:  Nat Rev Endocrinol       Date:  2016-11-04       Impact factor: 43.330

Review 2.  Endocrine consequences of anorexia nervosa.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-02       Impact factor: 32.069

Review 3.  Potential applications for rhIGF-I: Bone disease and IGFI.

Authors:  Marisol Bahamonde; Madhusmita Misra
Journal:  Growth Horm IGF Res       Date:  2020-03-23       Impact factor: 2.372

Review 4.  Anorexia Nervosa and Its Associated Endocrinopathy in Young People.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Horm Res Paediatr       Date:  2016-02-11       Impact factor: 2.852

5.  Body composition, hemodynamic, and biochemical parameters of young female normal-weight oligo-amenorrheic and eumenorrheic athletes and nonathletes.

Authors:  Vibha Singhal; Maria de Lourdes Eguiguren; Lindsey Eisenbach; Hannah Clarke; Meghan Slattery; Kamryn Eddy; Kathryn E Ackerman; Madhusmita Misra
Journal:  Ann Nutr Metab       Date:  2014-10-31       Impact factor: 3.374

Review 6.  Neuroendocrine consequences of anorexia nervosa in adolescents.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Endocr Dev       Date:  2009-11-24

7.  Bone metabolism in adolescent boys with anorexia nervosa.

Authors:  Madhusmita Misra; Debra K Katzman; Jennalee Cord; Stephanie J Manning; Nara Mendes; David B Herzog; Karen K Miller; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

8.  Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls.

Authors:  Madhusmita Misra; Miriam A Bredella; Patrika Tsai; Nara Mendes; Karen K Miller; Anne Klibanski
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-10       Impact factor: 4.310

9.  Follow-up of bone mineral density and body composition in adolescents with restrictive anorexia nervosa: role of dual-energy X-ray absorptiometry.

Authors:  E Franzoni; F Ciccarese; E Di Pietro; G Facchini; F Moscano; L Iero; A Monaldi; G Battista; A Bazzocchi
Journal:  Eur J Clin Nutr       Date:  2013-12-18       Impact factor: 4.016

10.  Percentage extremity fat, but not percentage trunk fat, is lower in adolescent boys with anorexia nervosa than in healthy adolescents.

Authors:  Madhusmita Misra; Debra K Katzman; Jennalee Cord; Stephanie J Manning; Diane Mickley; David B Herzog; Karen K Miller; Anne Klibanski
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.